however, the market scenario has shifted focus towards oral GLP-1 receptor agonists, incretin agonists, triple agonists, and amylin-based approaches targeting obesity as a metabolic disease rather than merely focusing on its weight management
found that irisin treatment improved prefrontal cortical energy metabolism in CUS rats, as shown by increased activity of mitochondrial complexes I, II, and IV, resulting in improved depression-like behaviors (Wang and Pan, 2016)
[DOI] [PubMed] [Google Scholar] 42.Wang T, Smith DA, Campbell C, Mokaya J, Freeman O, Salih H, McNaughton AL, Cripps S, Vrnai KA, Noble T, Woods K, Collier J, Jeffery K, Davies J, Barnes E, Matthews PC, Hepatitis B
When compared to other medications for obesity management, orlistat stands out primarily due to its gastrointestinal side effects which are typically manageable
thch Ngc Tho mua ti rocy.vn c xp hng 5 5 sao Sn phm chnh hng, y tem mc